Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali.
Laverdure S, Kazadi D, Kone K, Callier V, Dabitao D, Dennis D, Haidara MC, Hunsberger S, Mbaya OT, Ridzon R, Sereti I, Shaw-Saliba K; InVITE Study Team. Laverdure S, et al. Among authors: dabitao d. Int J Infect Dis. 2024 May;142:106985. doi: 10.1016/j.ijid.2024.106985. Epub 2024 Feb 28. Int J Infect Dis. 2024. PMID: 38417612 Free article.
Seasonal Malaria Chemoprevention Therapy in Children Up To 9 Years of Age: Protocol for a Cluster-Randomized Trial Study.
Toure M, Shaffer JG, Sanogo D, Keita S, Keita M, Kane F, Traore B, Dabitao D, Kone A, Doumbia CO, Keating J, Yukich J, Hansson HH, Barry AE, Diakité M, Alifrangis M, Doumbia S. Toure M, et al. Among authors: dabitao d. JMIR Res Protoc. 2024 Jan 22;13:e51660. doi: 10.2196/51660. JMIR Res Protoc. 2024. PMID: 38252481 Free PMC article.
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Lee AW, Liu K, Lhomme E, Blie J, McCullough J, Onorato MT, Connor L, Simon JK, Dubey S, VanRheenen S, Deutsch J, Owens A, Morgan A, Welebob C, Hyatt D, Nair S, Hamzé B, Guindo O, Sow SO, Beavogui AH, Leigh B, Samai M, Akoo P, Serry-Bangura A, Fleck S, Secka F, Lowe B, Watson-Jones D, Roy C, Hensley LE, Kieh M, Coller BG; PREVAC Study Team. Lee AW, et al. Clin Infect Dis. 2024 Apr 10;78(4):870-879. doi: 10.1093/cid/ciad693. Clin Infect Dis. 2024. PMID: 37967326 Free PMC article. Clinical Trial.
Hematological profiles of patients with tuberculosis and nontuberculous mycobacteria infections in Bamako, Mali.
Sanogo F, Kodio O, Sarro YS, Diarra B, Coulibaly G, Tolofoudie M, Fofana DB, Maiga A, Somboro AM, Diallo F, G Togo AC, Somboro A, Baya B, Kone B, Sanogo M, Dabitao D, Kone A, Diakite M, Doumbia S, Mamoudou M. Sanogo F, et al. Among authors: dabitao d. Int J Mycobacteriol. 2023 Jul-Sep;12(3):235-240. doi: 10.4103/ijmy.ijmy_208_22. Int J Mycobacteriol. 2023. PMID: 37721226 Free article.
Relationship between patient sex and anatomical sites of extrapulmonary tuberculosis in Mali.
Baya B, Sanogo I, Kone M, Soumare D, Ouattara K, Somboro A, Wague M, Coulibaly N, Koloma I, Coulibaly M, Nantoume M, Perou M, Kone K, Coulibaly D, Boukary Diarra H, Kone B, Diarra A, Coulibaly MD, Sanogo M, Diarra B, Diakite M, Achenbach CJ, Doumbia S, Bishai WR, Klein SL, Holl JL, Diallo S, Murphy RL, Toloba Y, Dabitao D. Baya B, et al. Among authors: dabitao d. J Clin Tuberc Other Mycobact Dis. 2023 Aug 9;33:100389. doi: 10.1016/j.jctube.2023.100389. eCollection 2023 Dec. J Clin Tuberc Other Mycobact Dis. 2023. PMID: 37637324 Free PMC article.
Challenges of conducting an international observational study to assess immunogenicity of multiple COVID-19 vaccines.
Sardana R, Kingebeni PM, Snc WA, Beavogui AH, Biampata JL, Dabitao D, de Blas PDCG, Gayedyu-Dennis D, Haidara MC, Jargalsaikhan G, Nyuangar G, Purnama A, Palacios GR, Samake S, Tounkara M, Weyers S, Zulkhuu D, Hunsberger S, Ridzon R. Sardana R, et al. Among authors: dabitao d. PLOS Glob Public Health. 2023 Jun 20;3(6):e0001918. doi: 10.1371/journal.pgph.0001918. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37339111 Free PMC article.
Clinical evaluation of commercial SARS-CoV-2 serological assays in a malaria endemic setting.
Dabitao D, Shaw-Saliba K, Konate DS, Highbarger HC, Lallemand P, Sanogo I, Rehman T, Wague M, Coulibaly N, Kone B, Baya B, Diakite SAS, Samake S, Akpa E, Tounkara M, Laverdure S, Doumbia S, Lane HC, Diakite M, Dewar RL. Dabitao D, et al. J Immunol Methods. 2023 Jun;517:113488. doi: 10.1016/j.jim.2023.113488. Epub 2023 May 11. J Immunol Methods. 2023. PMID: 37179012 Free PMC article.
Randomized Trial of Vaccines for Zaire Ebola Virus Disease.
PREVAC Study Team; Kieh M, Richert L, Beavogui AH, Grund B, Leigh B, D'Ortenzio E, Doumbia S, Lhomme E, Sow S, Vatrinet R, Roy C, Kennedy SB, Faye S, Lees S, Millimouno NP, Camara AM, Samai M, Deen GF, Doumbia M, Espérou H, Pierson J, Watson-Jones D, Diallo A, Wentworth D, McLean C, Simon J, Wiedemann A, Dighero-Kemp B, Hensley L, Lane HC, Levy Y, Piot P, Greenwood B, Chêne G, Neaton J, Yazdanpanah Y. PREVAC Study Team, et al. N Engl J Med. 2022 Dec 29;387(26):2411-2424. doi: 10.1056/NEJMoa2200072. Epub 2022 Dec 14. N Engl J Med. 2022. PMID: 36516078 Clinical Trial.
A Decade of Progress Accelerating Malaria Control in Mali: Evidence from the West Africa International Center of Excellence for Malaria Research.
Doumbia S, Sogoba N, Diakite M, Toure M, Keita M, Konaté D, Diawara SI, Diarra A, Sanogo D, Kane F, Diakite SAS, Traore K, Thiam SM, Traoré SF, Cisse I, Mihigo J, Coulibaly MB, Dabitao D, Alifrangis M, Barry AE, Müller GC, Beier JC, Shaffer JG. Doumbia S, et al. Among authors: dabitao d. Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):75-83. doi: 10.4269/ajtmh.21-1309. Print 2022 Oct 11. Am J Trop Med Hyg. 2022. PMID: 36228923 Free PMC article.
36 results